Scarica l'app Stockscreener
9.42
2.38%
-0.23
Dopo l'orario di chiusura:
9.42
Precedente Chiudi:
$9.65
Aprire:
$9.66
Volume 24 ore:
92,620
Relative Volume:
1.48
Capitalizzazione di mercato:
$244.94M
Reddito:
$26.00M
Utile/perdita netta:
$-219.71M
Rapporto P/E:
-0.1892
EPS:
-49.8
Flusso di cassa netto:
$-51.37M
1 W Prestazione:
-6.73%
1M Prestazione:
-1.87%
6M Prestazione:
-10.88%
1 anno Prestazione:
-56.95%
Intervallo 1D:
$9.33
$10.20
Intervallo di 1 settimana:
$9.31
$10.27
Portata 52W:
$8.46
$26.50
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Nome
Cartesian Therapeutics Inc
Settore
Industria
Telefono
301-348-8698
Indirizzo
7495 NEW HORIZON WAY, FREDERICK
Confronta RNAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNAC
Cartesian Therapeutics Inc
|
9.42 | 244.94M | 26.00M | -219.71M | -51.37M | -49.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-08-06 | Iniziato | TD Cowen | Buy |
| 2024-07-02 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-06-04 | Iniziato | Oppenheimer | Outperform |
| 2024-05-24 | Iniziato | Mizuho | Buy |
| 2024-04-23 | Reiterato | H.C. Wainwright | Buy |
| 2024-04-23 | Iniziato | Leerink Partners | Outperform |
| 2023-08-18 | Downgrade | SVB Securities | Outperform → Market Perform |
| 2022-06-14 | Reiterato | Needham | Buy |
| 2022-06-06 | Iniziato | SVB Leerink | Outperform |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-01-26 | Aggiornamento | Mizuho | Neutral → Buy |
| 2020-10-01 | Downgrade | Mizuho | Buy → Neutral |
| 2020-10-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-06-12 | Downgrade | Stifel | Buy → Hold |
| 2020-04-28 | Iniziato | H.C. Wainwright | Buy |
| 2020-01-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-01-21 | Iniziato | William Blair | Outperform |
| 2018-06-27 | Iniziato | Janney | Buy |
| 2017-03-30 | Reiterato | UBS | Buy |
Mostra tutto
Cartesian Therapeutics Inc Borsa (RNAC) Ultime notizie
Is Cartesian Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Cartesian Therapeutics Inc 1S70 Stock Analysis and ForecastStochastic Oscillator Alerts & Double Digit Trading Ideas - earlytimes.in
Can Cartesian Therapeutics Inc. (1S70) stock expand revenue streams2025 AllTime Highs & Free Reliable Trade Execution Plans - newser.com
Will Cartesian Therapeutics Inc. (1S70) stock outperform benchmarksJuly 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Combining price and volume data for Cartesian Therapeutics Inc.Forecast Cut & Free Weekly Chart Analysis and Trade Guides - newser.com
Will earnings trigger a reversal in Cartesian Therapeutics Inc.M&A Rumor & Safe Swing Trade Setups - newser.com
Smart tools for monitoring Cartesian Therapeutics Inc.’s price actionMarket Activity Report & Safe Investment Capital Preservation Plans - newser.com
Forecasting Cartesian Therapeutics Inc. price range with options dataMarket Movers & Accurate Buy Signal Notifications - newser.com
Can trapped investors hope for a rebound in Cartesian Therapeutics Inc.2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
Is Cartesian Therapeutics Inc. stock entering bullish territoryWeekly Loss Report & Reliable Entry Point Alerts - newser.com
Developing predictive dashboards with Cartesian Therapeutics Inc. dataQuarterly Trade Report & Precise Swing Trade Alerts - newser.com
Custom strategy builders for tracking Cartesian Therapeutics Inc.Fed Meeting & Safe Capital Allocation Plans - newser.com
What macro factors could drive Cartesian Therapeutics Inc. (1S70) stock higherMarket Trend Summary & Daily Technical Forecast Reports - newser.com
Will Cartesian Therapeutics Inc. (1S70) stock enhance shareholder valueAnalyst Downgrade & Pattern Based Trade Signal System - newser.com
How to manage a losing position in Cartesian Therapeutics Inc.Weekly Stock Summary & Entry Point Confirmation Signals - newser.com
Published on: 2025-10-10 06:07:33 - newser.com
Applying big data sentiment scoring on Cartesian Therapeutics Inc.Share Buyback & Scalable Portfolio Growth Ideas - newser.com
Cartesian Therapeutics Inc Stock Analysis and ForecastTechnical Resistance Breaks & Trade Like a Pro Using AI Edge - earlytimes.in
How to interpret RSI for Cartesian Therapeutics Inc. stockWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Cartesian Therapeutics (NASDAQ:RNAC) - MarketBeat
Published on: 2025-10-09 04:13:52 - newser.com
Cartesian Therapeutics Inc (RNAC): What Does Valuation Ratios Tell Us? - fostersleader.com
Cartesian Therapeutics appoints June Seymour as chief accounting officer - Investing.com
Cartesian Therapeutics appoints June Seymour as chief accounting officer By Investing.com - Investing.com Canada
What analysts say about Cartesian Therapeutics Inc 1S70 stockLow Beta Stocks & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Live market analysis of Cartesian Therapeutics Inc.Earnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
What consensus target says about Cartesian Therapeutics Inc. (1S70) stockWeekly Profit Recap & Verified Momentum Watchlists - newser.com
Cartesian Therapeutics Inc. stock trend outlook and recovery pathMarket Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Cartesian Therapeutics Announces New Employment Inducement Grant - MarketScreener
Is Cartesian Therapeutics Inc a good long term investmentExit Strategy Tips & Free High Yield Portfolio Picks - earlytimes.in
Will Cartesian Therapeutics Inc. stock attract more institutional investorsJuly 2025 Opening Moves & Real-Time Buy Signal Alerts - newser.com
We Think Cartesian Therapeutics (NASDAQ:RNAC) Can Afford To Drive Business Growth - Sahm
TD Cowen Maintains Cartesian Therapeutics(RNAC.US) With Buy Rating - 富途牛牛
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Cartesian Therapeutics (RNAC) Awards Stock Options to New Employ - GuruFocus
Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cartesian Therapeutics Inc Azioni (RNAC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| English Emily | Chief Operations Officer |
Apr 15 '25 |
Option Exercise |
3.30 |
7,500 |
24,750 |
47,726 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
48,595 |
508,751 |
620,175 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
41,782 |
393,947 |
571,580 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
36,338 |
391,455 |
656,513 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
10.47 |
8,575 |
89,773 |
8,637,273 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
9.43 |
7,373 |
69,517 |
8,628,698 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
10.77 |
6,412 |
69,074 |
8,643,685 |
| SPRINGER TIMOTHY A | Director |
Mar 20 '25 |
Buy |
15.59 |
54,889 |
855,593 |
8,621,325 |
| SPRINGER TIMOTHY A | Director |
Mar 19 '25 |
Buy |
14.97 |
20,234 |
302,962 |
8,566,436 |
| SPRINGER TIMOTHY A | Director |
Mar 18 '25 |
Buy |
14.42 |
14,740 |
212,599 |
8,546,202 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):